Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

ATryn is the brand name of the anticoagulant antithrombin manufactured by the Massachusetts-based U.S. company GTC Biotherapeutics. It is made from the milk of goats that have been genetically modified to produce human antithrombin, a plasma protein with anticoagulant properties. Microinjection was used to insert human antithrombin genes into the cell nucleus of their embryos. ATryn is the first medicine produced using genetically engineered animals. GTC states that one genetically modified goat can produce the same amount of antithrombin in a year as 90,000 blood donations. GTC chose goats for the process because they reproduce more rapidly than cattle and produce more protein than rabbits or mice.

More on Wikipedia

Brand name: Atryn
Generic name/category: anticoagulant antithrombin, Anticoagulants, Genetic engineering
Company: Lundbeck
Country/Market: USA, North America
Indication(s)/use: prevention of peri-operative and peri-partum thromboembolic events
Target: Healthcare Professionals (HCP)
Tagline: Make a recombinant connection
Medium: Print ad
Size/duration: single-page
Publication/Aired: Blood – August 06, 2009
1 views
Sep 17, 2009

Visit AdPharm.net for more pharmaceutical ads